Abcam and SomaServe partner to commercialize novel cell delivery platform technology
Date | 17th, Dec 2019 |
---|---|
Source | News Medical - Scientific News Websites |
DESCRIPTION
Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNautâ Technology, have announced a partnership to commercialize the cell delivery potential of the polymer-based ‘bionic’ nanoparticles, which can carry a range of payloads directly to live cells.